Nøhr Mark K, Kroager Toke P, Sanggaard Kristian W, Knudsen Anders D, Stensballe Allan, Enghild Jan J, Ølholm Jens, Richelsen Bjørn, Pedersen Steen B
Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
PLoS One. 2016 Jul 20;11(7):e0159747. doi: 10.1371/journal.pone.0159747. eCollection 2016.
Adipose tissue inflammation is believed to play a pivotal role in the development obesity-related morbidities such as insulin resistance. However, it is not known how this (low-grade) inflammatory state develops. It has been proposed that the leakage of lipopolysaccharides (LPS), originating from the gut microbiota, through the gut epithelium could drive initiation of inflammation. To get a better understanding of which proteins and intracellular pathways are affected by LPS in adipocytes, we performed SILAC proteomic analysis and identified proteins that were altered in expression. Furthermore, we tested the anti-inflammatory compound resveratrol. A total of 927 proteins were quantified by the SILAC method and of these 57- and 64 were significantly up- and downregulated by LPS, respectively. Bioinformatic analysis (GO analysis) revealed that the upregulated proteins were especially involved in the pathways of respiratory electron transport chain and inflammation. The downregulated proteins were especially involved in protein glycosylation. One of the latter proteins, GALNT2, has previously been described to regulate the expression of liver lipases such as ANGPTL3 and apoC-III affecting lipid metabolism. Furthermore, LPS treatment reduced the protein levels of the insulin sensitizing adipokine, adiponectin, and proteins participating in the final steps of triglyceride- and cholesterol synthesis. Generally, resveratrol opposed the effect induced by LPS and, as such, functioning as an ameliorating factor in disease state. Using an unbiased proteomic approach, we present novel insight of how the proteome is altered in adipocytes in response to LPS as seen in obesity. We suggest that LPS partly exerts its detrimental effects by altering glycosylation processes of the cell, which is starting to emerge as important posttranscriptional regulators of protein expression. Furthermore, resveratrol could be a prime candidate in ameliorating dysfunctioning adipose tissue induced by inflammatory stimulation.
脂肪组织炎症被认为在肥胖相关疾病(如胰岛素抵抗)的发展中起关键作用。然而,尚不清楚这种(低度)炎症状态是如何发展的。有人提出,源自肠道微生物群的脂多糖(LPS)通过肠道上皮渗漏可能会引发炎症。为了更好地了解脂肪细胞中哪些蛋白质和细胞内途径受LPS影响,我们进行了稳定同位素标记氨基酸细胞培养(SILAC)蛋白质组学分析,并鉴定了表达发生变化的蛋白质。此外,我们测试了抗炎化合物白藜芦醇。通过SILAC方法共定量了927种蛋白质,其中57种和64种分别被LPS显著上调和下调。生物信息学分析(基因本体分析)显示,上调的蛋白质尤其参与呼吸电子传递链和炎症途径。下调的蛋白质尤其参与蛋白质糖基化。后一种蛋白质之一,GALNT2,此前已被描述为调节肝脏脂肪酶(如血管生成素样蛋白3和载脂蛋白C-III)的表达,从而影响脂质代谢。此外,LPS处理降低了胰岛素增敏脂肪因子脂联素的蛋白质水平以及参与甘油三酯和胆固醇合成最后步骤的蛋白质水平。一般来说,白藜芦醇对抗LPS诱导的效应,因此在疾病状态下起到改善因子的作用。通过无偏向蛋白质组学方法,我们揭示了肥胖时脂肪细胞蛋白质组如何响应LPS而发生改变的新见解。我们认为,LPS部分通过改变细胞的糖基化过程发挥其有害作用,而糖基化过程正开始成为蛋白质表达的重要转录后调节因子。此外,白藜芦醇可能是改善炎症刺激诱导的脂肪组织功能障碍的主要候选药物。